|
GTX20671
|
GeneTex International Corporation
|
AP Enhancer
|
|
IHC-Fr, IHC-P
|
|
|
GTX27468
|
GeneTex International Corporation
|
AP chromogen BCIP/NBT (ready-to-use)
|
|
Dot, IHC, IHC-Fr, IHC-P, WB
|
|
|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
GTX30924
|
GeneTex International Corporation
|
Immuno In Situ Mount
|
|
IHC
|
|
|
GTX30942
|
GeneTex International Corporation
|
Fast Red Super
|
|
IHC
|
|
|
GTX30943
|
GeneTex International Corporation
|
BCIP/NBT Substrate
|
|
ICC/IF, IHC, ISH, WB
|
|
|
GTX30944
|
GeneTex International Corporation
|
Alkaline Phosphatase Enhancer
|
|
ICC/IF, IHC, ISH
|
|
|
GTX30954
|
GeneTex International Corporation
|
Streptavidin (AP)
|
|
ELISA, IHC, WB
|
|
|
GTX30968
|
GeneTex International Corporation
|
Endogenous Alkaline phosphatase blocking kit
|
|
IHC
|
|
|
GTX73326
|
GeneTex International Corporation
|
BCIP/NBT chromogen/substrate
|
|
IHC
|
|
|
GTX73347
|
GeneTex International Corporation
|
Endo/Blocker
|
|
IHC
|
|
|
GTX85909
|
GeneTex International Corporation
|
Streptavidin (AP)
|
|
ELISA, IHC, WB
|
|
|
TRC-N389945-500mg
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|
|
TRC-N389945-1g
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|
|
TRC-N389945-100mg
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|
|
HY-122808-100mg
|
MedChemexpress LLC
|
(-)-Camphoric acid [CAS 560-09-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-122808-1mL
|
MedChemexpress LLC
|
(-)-Camphoric acid [CAS 560-09-8] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-112929B-10mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-100mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-5mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-50mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-1mL
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-126390-1mg
|
MedChemexpress LLC
|
(E/Z)-BCI [CAS 15982-84-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-18956-2mg
|
MedChemexpress LLC
|
(E/Z)-Icerguastat [CAS 13098-73-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-W007599-100g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
